Postmarketing Vaccine Safety Assessments: Important Work in Progress
JAMA
.
2024 Mar 19;331(11):915-917.
doi: 10.1001/jama.2023.26630.
Authors
Kathryn M Edwards
1
,
Marie R Griffin
2
Affiliations
1
Vanderbilt University Medical Center, Nashville, Tennessee.
2
School of Medicine, Vanderbilt University, Nashville, Tennessee.
PMID:
38502085
DOI:
10.1001/jama.2023.26630
No abstract available
Publication types
Comment
MeSH terms
Outcome Assessment, Health Care* / standards
Product Surveillance, Postmarketing*
Vaccine Development* / standards
Vaccines* / adverse effects
Vaccines* / therapeutic use
Substances
Vaccines